Establishment and Clinical Significance of the Patient-Derived Xenograft Model of Colorectal Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Patient-derived xenograft (PDX) models accurately reflect human colorectal cancer (CRC) heterogeneity. Primary tumor malignancy is key to successful PDX model development, aiding personalized treatment strategies.
Area Of Science
- Oncology
- Preclinical Research
- Cancer Modeling
Background
- Patient-derived xenograft (PDX) models are crucial for understanding cancer heterogeneity and improving preclinical research.
- These models offer a valuable platform for evaluating drug efficacy and developing personalized treatment strategies.
Purpose Of The Study
- To investigate factors influencing tumor formation rates in patient-derived xenograft (PDX) colorectal cancer (CRC) models.
- To perform preliminary drug sensitivity testing using established CRC-PDX models.
Main Methods
- Tumor tissues from 60 CRC patients were used to establish PDX models in NSG mice, subcultured to the F3 generation.
- Factors affecting tumorigenicity were analyzed, including primary tumor characteristics and preoperative markers.
- Drug sensitivity was assessed using 5-fluorouracil, oxaliplatin, and propofol.
Main Results
- Tumorigenesis was achieved in 62% of CRC tissue transplants.
- Primary tumor malignancy (stage, differentiation), CEA levels, and tumor location impacted PDX model success.
- CRC-PDX models demonstrated high histopathological consistency with primary tumors.
- Chemotherapy inhibited tumor growth; propofol showed potential in managing side effects like diarrhea and protecting intestinal mucosa.
Conclusions
- The established CRC-PDX model effectively preserves the biological characteristics of primary tumors.
- These PDX models serve as a reliable reference for personalized CRC treatment.
- Primary tumor malignancy is the principal determinant of PDX model tumorigenesis rates.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.